Inventor
DELUCCA GEORGE V
US36 patents
⚠️ This page may combine multiple inventors who share the name “DELUCCA GEORGE V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB PHARMA CO
15 patentsUS6525069B1Feb 25, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO52 citations95
US6759411B2Jul 6, 2004
Heterocyclic piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO26 citations92
US6605623B1Aug 12, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO36 citations92
US6521592B2Feb 18, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO28 citations92
US6441001B1Aug 27, 2002
2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO26 citations92
US6974869B2Dec 13, 2005
Piperizinones as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO13 citations84
US6492400B1Dec 10, 2002
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO15 citations84
US6780857B2Aug 24, 2004
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO6 citations73
US6486180B1Nov 26, 2002
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO10 citations72
US6706735B2Mar 16, 2004
2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations63
US6919368B2Jul 19, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations62
US6906066B2Jun 14, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations61
US6875776B2Apr 5, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations61
US7514430B2Apr 7, 2009
Piperizinones as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
US7312222B2Dec 25, 2007
Heterocyclic piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
BRISTOL MYERS SQUIBB CO
14 patentsUS9458156B2Oct 4, 2016
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO25 citations94
US8362065B2Jan 29, 2013
Carbazole carboxamide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO32 citations92
US9273014B2Mar 1, 2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO14 citations83
US8999918B2Apr 7, 2015
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
BRISTOL MYERS SQUIBB CO9 citations83
US9492460B2Nov 15, 2016
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US9725449B2Aug 8, 2017
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US7550486B2Jun 23, 2009
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO2 citations63
US7351720B2Apr 1, 2008
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO4 citations63
US9133139B2Sep 15, 2015
Fluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO2 citations62
US10112941B2Oct 30, 2018
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations52
US7291744B2Nov 6, 2007
N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO2 citations52
US10106559B2Oct 23, 2018
Substituted tetrahydrocarbazole and carbazole carboxamide compounds
BRISTOL MYERS SQUIBB CO0 citations51
US9751879B2Sep 5, 2017
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO1 citations51
US9242941B2Jan 26, 2016
Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO0 citations41